Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,575
Closed -$11K 3130
2023
Q1
$11K Sell
14,575
-1,860
-11% -$1.73K ﹤0.01% 2801
2022
Q4
$16K Hold
16,435
﹤0.01% 2803
2022
Q3
$36K Buy
16,435
+62
+0.4% +$214 ﹤0.01% 2603
2022
Q2
$57K Sell
16,373
-3,079
-16% -$11.5K ﹤0.01% 2411
2022
Q1
$98K Sell
19,452
-1,479
-7% -$7.49K ﹤0.01% 2202
2021
Q4
$131K Sell
20,931
-43
-0.2% -$294 ﹤0.01% 2035
2021
Q3
$167K Sell
20,974
-1,061
-5% -$8.73K ﹤0.01% 2024
2021
Q2
$165K Buy
+22,035
New +$154K ﹤0.01% 2060

Other funds holding VXRT

Amalgamated Bank's VXRT Position: Q2 2023 in Review

Amalgamated Bank sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 14,575 shares — an estimated $11K sold.

Amalgamated Bank first reported a position in VXRT in Q2 2021 and held it in 8 quarters. The position peaked at $167K in Q3 2021. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

  • Amalgamated Bank reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
  • Amalgamated Bank sold 14,575 Vaxart shares in Q2 2023, an estimated $11K.
  • Amalgamated Bank first reported a position in Vaxart in Q2 2021 and held it in 8 quarters.
  • Amalgamated Bank's Vaxart position peaked at $167K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Amalgamated Bank's 13F filing for Q2 2023, filed 11 Aug 2023.